CareDx to Report Second Quarter 2024 Financial Results
16 Luglio 2024 - 1:05PM
Business Wire
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on
the discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers – today announced it will report financial
results for the second quarter 2024 after market close on
Wednesday, July 31, 2024. Company management will host a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may
do so by dialing 1-800-267-6316 for domestic callers or
1-203-518-9783 for international callers. Please reference
Conference ID: CareDx. To listen to a live webcast, please visit
the investor relations section of CareDx’s website at:
investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a
leading precision medicine solutions company focused on the
discovery, development, and commercialization of clinically
differentiated, high-value healthcare solutions for transplant
patients and caregivers. CareDx offers testing services, products,
and digital healthcare solutions along the pre- and post-transplant
patient journey and is the leading provider of genomics-based
information for transplant patients. For more information, please
visit: www.CareDx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240716115420/en/
CareDx, Inc. Investor Relations Greg Chodaczek
investor@caredx.com
Grafico Azioni CareDx (NASDAQ:CDNA)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni CareDx (NASDAQ:CDNA)
Storico
Da Gen 2024 a Gen 2025
